Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial - Vranckx, P; Valgimigli, M; Eckardt, L (Eur Heart J, 2020)